rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2006-7-26
|
pubmed:abstractText |
To characterise the comparative potency of optically pure (R)- and (S)-verapamil as regards negative dromotropic effects on atrioventricular (AV) node conduction and to compare the hemodynamic effects of single doses of the enantiomers in healthy volunteers.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0031-6970
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
613-9
|
pubmed:meshHeading |
pubmed-meshheading:16823584-Administration, Oral,
pubmed-meshheading:16823584-Adult,
pubmed-meshheading:16823584-Area Under Curve,
pubmed-meshheading:16823584-Blood Pressure,
pubmed-meshheading:16823584-Calcium Channel Blockers,
pubmed-meshheading:16823584-Cross-Over Studies,
pubmed-meshheading:16823584-Electrocardiography,
pubmed-meshheading:16823584-Half-Life,
pubmed-meshheading:16823584-Heart Conduction System,
pubmed-meshheading:16823584-Humans,
pubmed-meshheading:16823584-Linear Models,
pubmed-meshheading:16823584-Male,
pubmed-meshheading:16823584-Stereoisomerism,
pubmed-meshheading:16823584-Verapamil
|
pubmed:year |
2006
|
pubmed:articleTitle |
Cardiovascular effects of (R)- and (S)-verapamil and racemic verapamil in humans: a placebo-controlled study.
|
pubmed:affiliation |
Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|